Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Altus Pharmaceuticals Inc. (ALTU) since 2006 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Altus Pharmaceuticals Inc.. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1340744.
Total stock buying since 2006: $0.
Total stock sales since 2006: $15,875,832.
Total stock option exercises since 2006: $726,180.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2009 | 0 | $0 | 2,404,298 | $576,453 | 0 | $0 |
| 2007 | 0 | $0 | 142,150 | $2,109,852 | 125,750 | $492,940 |
| 2006 | 0 | $0 | 902,599 | $13,189,527 | 59,500 | $233,240 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2009-09 | 0 | $0 | 600,000 | $194,400 | 0 | $0 |
| 2009-04 | 0 | $0 | 1,804,298 | $382,053 | 0 | $0 |
| 2007-12 | 0 | $0 | 2,300 | $23,319 | 34,300 | $134,456 |
| 2007-11 | 0 | $0 | 2,300 | $27,275 | 2,300 | $9,016 |
| 2007-10 | 0 | $0 | 2,300 | $25,908 | 2,300 | $9,016 |
| 2007-09 | 0 | $0 | 2,300 | $23,696 | 2,300 | $9,016 |
| 2007-08 | 0 | $0 | 12,750 | $130,922 | 12,750 | $49,980 |
| 2007-07 | 0 | $0 | 31,900 | $368,775 | 21,000 | $82,320 |
| 2007-04 | 0 | $0 | 14,875 | $223,089 | 11,750 | $46,060 |
| 2007-03 | 0 | $0 | 22,925 | $351,596 | 13,550 | $53,116 |
| 2007-02 | 0 | $0 | 24,250 | $436,601 | 11,750 | $46,060 |
| 2007-01 | 0 | $0 | 26,250 | $498,671 | 13,750 | $53,900 |
| 2006-12 | 0 | $0 | 37,750 | $723,971 | 33,250 | $130,340 |
| 2006-11 | 0 | $0 | 47,100 | $788,101 | 26,250 | $102,900 |
| 2006-07 | 0 | $0 | 817,749 | $11,677,455 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-09-14 | Liddle David E (10% Owner) | Sale | 300,000 | .32 | 97,200 |
| 2009-09-14 | Young Philip M (10% Owner) | Sale | 300,000 | .32 | 97,200 |
| 2009-04-20 | Warburg Pincus & Co (10% Owner) | Sale | 458,231 | .20 | 93,937 |
| 2009-04-17 | Warburg Pincus & Co (10% Owner) | Sale | 276,219 | .21 | 58,005 |
| 2009-04-16 | Warburg Pincus & Co (10% Owner) | Sale | 50,672 | .21 | 10,691 |
| 2009-04-15 | Warburg Pincus & Co (10% Owner) | Sale | 129,798 | .21 | 26,997 |
| 2009-04-14 | Warburg Pincus & Co (10% Owner) | Sale | 116,675 | .21 | 24,968 |
| 2009-04-13 | Warburg Pincus & Co (10% Owner) | Sale | 112,000 | .21 | 23,744 |
| 2009-04-09 | Warburg Pincus Llc (10% Owner) | Sale | 363,419 | .22 | 78,861 |
| 2009-04-08 | Warburg Pincus Llc (10% Owner) | Sale | 127,300 | .22 | 27,624 |
| 2009-04-07 | Warburg Pincus Llc (10% Owner) | Sale | 169,984 | .22 | 37,226 |
| 2007-12-17 | Lieber Jonathan I (VP, CFO and Treasurer) | Sale | 1,800 | 10.03 | 18,054 |
| 2007-12-17 | Lieber Jonathan I (VP, CFO and Treasurer) | Option Ex | 1,800 | 3.92 | 7,056 |
| 2007-12-13 | Berkle Sheldon (President and CEO) | Option Ex | 32,000 | 3.92 | 125,440 |
| 2007-12-03 | Gallotto Robert (VP, Strategic Planning) | Sale | 500 | 10.53 | 5,265 |
| 2007-12-03 | Gallotto Robert (VP, Strategic Planning) | Option Ex | 500 | 3.92 | 1,960 |
| 2007-11-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Sale | 1,800 | 11.35 | 20,430 |
| 2007-11-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Option Ex | 1,800 | 3.92 | 7,056 |
| 2007-11-01 | Gallotto Robert (VP, Strategic Planning) | Sale | 500 | 13.69 | 6,845 |
| 2007-11-01 | Gallotto Robert (VP, Strategic Planning) | Option Ex | 500 | 3.92 | 1,960 |
| 2007-10-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Sale | 1,800 | 11.46 | 20,628 |
| 2007-10-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Option Ex | 1,800 | 3.92 | 7,056 |
| 2007-10-01 | Gallotto Robert (VP, Strategic Planning) | Sale | 500 | 10.56 | 5,280 |
| 2007-10-01 | Gallotto Robert (VP, Strategic Planning) | Option Ex | 500 | 3.92 | 1,960 |
| 2007-09-17 | Lieber Jonathan I (VP, CFO and Treasurer) | Sale | 1,800 | 10.27 | 18,486 |
| 2007-09-17 | Lieber Jonathan I (VP, CFO and Treasurer) | Option Ex | 1,800 | 3.92 | 7,056 |
| 2007-09-04 | Gallotto Robert (VP, Strategic Planning) | Sale | 500 | 10.42 | 5,210 |
| 2007-09-04 | Gallotto Robert (VP, Strategic Planning) | Option Ex | 500 | 3.92 | 1,960 |
| 2007-08-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Sale | 9,000 | 10.42 | 93,780 |
| 2007-08-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Option Ex | 9,000 | 3.92 | 35,280 |
| 2007-08-08 | Gallotto Robert (VP, Strategic Planning) | Sale | 500 | 10.00 | 5,000 |
| 2007-08-08 | Gallotto Robert (VP, Strategic Planning) | Option Ex | 500 | 3.92 | 1,960 |
| 2007-08-01 | Berkle Sheldon (President and CEO) | Sale | 3,250 | 9.89 | 32,142 |
| 2007-08-01 | Berkle Sheldon (President and CEO) | Option Ex | 3,250 | 3.92 | 12,740 |
| 2007-07-19 | Berkle Sheldon (President and CEO) | Sale | 8,000 | 11.54 | 92,320 |
| 2007-07-19 | Berkle Sheldon (President and CEO) | Option Ex | 8,000 | 3.92 | 31,360 |
| 2007-07-18 | Gallotto Robert (VP, Strategic Planning) | Sale | 1,500 | 11.90 | 17,850 |
| 2007-07-18 | Gallotto Robert (VP, Strategic Planning) | Option Ex | 1,500 | 3.92 | 5,880 |
| 2007-07-18 | Margolin Alexey L (Chief Scientific Officer) | Sale | 10,900 | 11.55 | 125,895 |
| 2007-07-18 | Berkle Sheldon (President and CEO) | Sale | 11,500 | 11.54 | 132,710 |
| 2007-07-18 | Berkle Sheldon (President and CEO) | Option Ex | 11,500 | 3.92 | 45,080 |
| 2007-04-02 | Gallotto Robert (VP, Strategic Planning) | Sale | 2,000 | 14.93 | 29,860 |
| 2007-04-02 | Gallotto Robert (VP, Strategic Planning) | Option Ex | 2,000 | 3.92 | 7,840 |
| 2007-04-02 | Margolin Alexey L (Chief Scientific Officer) | Sale | 3,125 | 14.94 | 46,687 |
| 2007-04-02 | Berkle Sheldon (President and CEO) | Sale | 9,750 | 15.03 | 146,542 |
| 2007-04-02 | Berkle Sheldon (President and CEO) | Option Ex | 9,750 | 3.92 | 38,220 |
| 2007-03-22 | Margolin Alexey L (Chief Scientific Officer) | Sale | 3,125 | 16.00 | 50,000 |
| 2007-03-19 | Margolin Alexey L (Chief Scientific Officer) | Sale | 3,125 | 14.88 | 46,500 |
| 2007-03-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Sale | 1,800 | 14.23 | 25,614 |
| 2007-03-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Option Ex | 1,800 | 3.92 | 7,056 |
| 2007-03-05 | Margolin Alexey L (Chief Scientific Officer) | Sale | 3,125 | 14.19 | 44,343 |
| 2007-03-01 | Gallotto Robert (VP, Strategic Planning) | Sale | 2,000 | 16.13 | 32,259 |
| 2007-03-01 | Gallotto Robert (VP, Strategic Planning) | Option Ex | 2,000 | 3.92 | 7,840 |
| 2007-03-01 | Berkle Sheldon (President and CEO) | Sale | 9,750 | 15.68 | 152,880 |
| 2007-03-01 | Berkle Sheldon (President and CEO) | Option Ex | 9,750 | 3.92 | 38,220 |
| 2007-02-21 | Margolin Alexey L (Chief Scientific Officer) | Sale | 600 | 17.29 | 10,374 |
| 2007-02-20 | Margolin Alexey L (Chief Scientific Officer) | Sale | 5,650 | 17.37 | 98,140 |
| 2007-02-05 | Margolin Alexey L (Chief Scientific Officer) | Sale | 6,250 | 18.12 | 113,250 |
| 2007-02-01 | Gallotto Robert (VP, Strategic Planning) | Sale | 2,000 | 18.45 | 36,900 |
| 2007-02-01 | Gallotto Robert (VP, Strategic Planning) | Option Ex | 2,000 | 3.92 | 7,840 |
| 2007-02-01 | Berkle Sheldon (President and CEO) | Sale | 9,750 | 18.25 | 177,937 |
| 2007-02-01 | Berkle Sheldon (President and CEO) | Option Ex | 9,750 | 3.92 | 38,220 |
| 2007-01-22 | Margolin Alexey L (Chief Scientific Officer) | Sale | 6,250 | 18.73 | 117,062 |
| 2007-01-16 | Lieber Jonathan I (VP, CFO and Treasurer) | Sale | 2,000 | 19.24 | 38,480 |
| 2007-01-16 | Lieber Jonathan I (VP, CFO and Treasurer) | Option Ex | 2,000 | 3.92 | 7,840 |
| 2007-01-08 | Margolin Alexey L (Chief Scientific Officer) | Sale | 6,250 | 19.40 | 121,249 |
| 2007-01-03 | Gallotto Robert (VP, Strategic Planning) | Sale | 2,000 | 18.90 | 37,800 |
| 2007-01-03 | Gallotto Robert (VP, Strategic Planning) | Option Ex | 2,000 | 3.92 | 7,840 |
| 2007-01-03 | Berkle Sheldon (President and CEO) | Sale | 9,750 | 18.88 | 184,080 |
| 2007-01-03 | Berkle Sheldon (President and CEO) | Option Ex | 9,750 | 3.92 | 38,220 |
| 2006-12-27 | Margolin Alexey L (Chief Scientific Officer) | Sale | 6,250 | 19.77 | 123,562 |
| 2006-12-22 | Berkle Sheldon (President and CEO) | Option Ex | 8,000 | 3.92 | 31,360 |
| 2006-12-20 | Gallotto Robert (VP, Strategic Planning) | Sale | 7,000 | 20.00 | 140,000 |
| 2006-12-20 | Gallotto Robert (VP, Strategic Planning) | Option Ex | 7,000 | 3.92 | 27,440 |
| 2006-12-20 | Berkle Sheldon (President and CEO) | Sale | 6,500 | 20.07 | 130,455 |
| 2006-12-20 | Berkle Sheldon (President and CEO) | Option Ex | 6,500 | 3.92 | 25,480 |
| 2006-12-11 | Margolin Alexey L (Chief Scientific Officer) | Sale | 6,250 | 19.21 | 120,062 |
| 2006-12-01 | Gallotto Robert (VP, Strategic Planning) | Sale | 2,000 | 17.83 | 35,660 |
| 2006-12-01 | Gallotto Robert (VP, Strategic Planning) | Option Ex | 2,000 | 3.92 | 7,840 |
| 2006-12-01 | Berkle Sheldon (President and CEO) | Sale | 9,750 | 17.87 | 174,232 |
| 2006-12-01 | Berkle Sheldon (President and CEO) | Option Ex | 9,750 | 3.92 | 38,220 |
| 2006-11-27 | Margolin Alexey L (Chief Scientific Officer) | Sale | 6,250 | 18.01 | 112,562 |
| 2006-11-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Sale | 2,000 | 18.61 | 37,220 |
| 2006-11-15 | Lieber Jonathan I (VP, CFO and Treasurer) | Option Ex | 2,000 | 3.92 | 7,840 |
| 2006-11-13 | Margolin Alexey L (Chief Scientific Officer) | Sale | 7,850 | 16.80 | 132,612 |
| 2006-11-01 | Gallotto Robert (VP, Strategic Planning) | Sale | 14,500 | 16.19 | 234,755 |
| 2006-11-01 | Gallotto Robert (VP, Strategic Planning) | Option Ex | 14,500 | 3.92 | 56,840 |
| 2006-11-01 | Berkle Sheldon (President and CEO) | Sale | 9,750 | 16.07 | 156,682 |
| 2006-11-01 | Berkle Sheldon (President and CEO) | Option Ex | 9,750 | 3.92 | 38,220 |
| 2006-07-31 | Vertex Pharmaceuticals Inc / Ma (10% Owner) | Sale | 817,749 | 14.28 | 11,677,455 |
Insider trading activities including stock purchases, stock sales, and option exercises of ALTU listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Altus Pharmaceuticals Inc. (symbol ALTU, CIK number 1340744) see the Securities and Exchange Commission (SEC) website.